Characterisation of Genome-Wide PLZF/RARA Target Genes

The PLZF/RARA fusion protein generated by the t(11;17)(q23;q21) translocation in acute promyelocytic leukaemia (APL) is believed to act as an oncogenic transcriptional regulator recruiting epigenetic factors to genes important for its transforming potential. However, molecular mechanisms associated with PLZF/RARA-dependent leukaemogenesis still remain unclear. We searched for specific PLZF/RARA target genes by ChIP-on-chip in the haematopoietic cell line U937 conditionally expressing PLZF/RARA. By comparing bound regions found in U937 cells expressing endogenous PLZF with PLZF/RARA-induced U937 cells, we isolated specific PLZF/RARA target gene promoters. We next analysed gene expression profiles of our identified target genes in PLZF/RARA APL patients and analysed DNA sequences and epigenetic modification at PLZF/RARA binding sites. We identify 413 specific PLZF/RARA target genes including a number encoding transcription factors involved in the regulation of haematopoiesis. Among these genes, 22 were significantly down regulated in primary PLZF/RARA APL cells. In addition, repressed PLZF/RARA target genes were associated with increased levels of H3K27me3 and decreased levels of H3K9K14ac. Finally, sequence analysis of PLZF/RARA bound sequences reveals the presence of both consensus and degenerated RAREs as well as enrichment for tissue-specific transcription factor motifs, highlighting the complexity of targeting fusion protein to chromatin. Our study suggests that PLZF/RARA directly targets genes important for haematopoietic development and supports the notion that PLZF/RARA acts mainly as an epigenetic regulator of its direct target genes.

[1]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[2]  H Phillip Koeffler,et al.  Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays. , 2003, Blood.

[3]  C. Tribioli,et al.  Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL , 1998, Nature Genetics.

[4]  A. Zelenetz,et al.  Clinical and Molecular Characterization of a Rare Syndrome of Acute Promyelocytic Leukemia Associated With Translocation , 2002 .

[5]  O. Poch,et al.  Cell-Specific Interaction of Retinoic Acid Receptors with Target Genes in Mouse Embryonic Fibroblasts and Embryonic Stem Cells , 2009, Molecular and Cellular Biology.

[6]  H. de Thé,et al.  PML–RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation , 2004, The Journal of experimental medicine.

[7]  M. Minden,et al.  PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. , 2010, Cancer cell.

[8]  M. L. Beau,et al.  Forced retinoic acid receptor α homodimers prime mice for APL-like leukemia , 2006 .

[9]  M. L. Le Beau,et al.  Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia. , 2006, Cancer cell.

[10]  Z. Darżynkiewicz,et al.  ASB-2 Inhibits Growth and Promotes Commitment in Myeloid Leukemia Cells* , 2002, The Journal of Biological Chemistry.

[11]  G. Behre,et al.  Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip. , 2008, Blood.

[12]  W. van Putten,et al.  Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value. , 2010, Blood.

[13]  S. Minucci,et al.  Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.

[14]  D. Grimwade,et al.  Acute promyelocytic leukemia: a paradigm for differentiation therapy. , 2010, Cancer treatment and research.

[15]  J. Inazawa,et al.  Identification of a novel fusion gene in a pre‐B acute lymphoblastic leukemia with t(1;19)(q23;p13) , 2004, Cancer science.

[16]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[17]  J. Dick,et al.  Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC. , 2009, Blood.

[18]  B. Raught,et al.  PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. , 2010, Cancer cell.

[19]  C. Tribioli,et al.  Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. , 1998, Nature genetics.

[20]  Hideaki Mitsui,et al.  Tumorigenesis and Neoplastic Progression Down-Regulation of DUSP 6 Expression in Lung Cancer Its Mechanism and Potential Role in Carcinogenesis , 2010 .

[21]  T. Jenuwein,et al.  Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. , 2007, Cancer cell.

[22]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[23]  P. Pandolfi,et al.  Transcriptional regulation of cellular transformation , 2000, Nature Medicine.

[24]  S. Inoue,et al.  Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.

[25]  T. Furukawa,et al.  Abrogation of DUSP6 by hypermethylation in human pancreatic cancer , 2005, Journal of Human Genetics.

[26]  E. Paietta,et al.  Expression of cell-surface antigens in acute promyelocytic leukaemia. , 2003, Best practice & research. Clinical haematology.

[27]  P. Pandolfi,et al.  Cytoplasmic PML function in TGF-β signalling , 2004, Nature.

[28]  P. Pandolfi,et al.  Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. , 2002, Developmental cell.

[29]  A. Look,et al.  Mechanisms of transcription factor deregulation in lymphoid cell transformation , 2007, Oncogene.

[30]  Denis Thieffry,et al.  CoCAS: a ChIP-on-chip analysis suite , 2009, Bioinform..

[31]  P. Pandolfi,et al.  The theory of APL revisited. , 2007, Current topics in microbiology and immunology.

[32]  H. Koeffler,et al.  Comparative Analysis of Genes Regulated by PML/RARα and PLZF/RARα in Response to Retinoic Acid Using Oligonucleotide Arrays , 2003 .

[33]  R. Nasr,et al.  Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Koretzky,et al.  PRAM-1 Is a Novel Adaptor Protein Regulated by Retinoic Acid (RA) and Promyelocytic Leukemia (PML)-RA Receptor α in Acute Promyelocytic Leukemia Cells* , 2001, The Journal of Biological Chemistry.

[35]  C. Muchardt,et al.  The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation. , 2009, Genes & development.

[36]  Manuela Zucknick,et al.  IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Pier Paolo Pandolfi,et al.  Cytoplasmic PML function in TGF-beta signalling. , 2004, Nature.

[38]  P. Pandolfi,et al.  RARα-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia , 2007, Proceedings of the National Academy of Sciences.

[39]  C. So,et al.  Forced homo-oligomerization of RARalpha leads to transformation of primary hematopoietic cells. , 2006, Cancer cell.

[40]  C. Peschle,et al.  Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling , 1997, Molecular and cellular biology.

[41]  A. Zelenetz,et al.  Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). , 1995, Blood.

[42]  M. Privalsky,et al.  DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[43]  A. Zelent,et al.  Differentiation therapy of acute myeloid leukemia: past, present and future. , 2009, Current opinion in hematology.

[44]  P. Pandolfi,et al.  Deregulated TGF-beta signaling in leukemogenesis. , 2005, Oncogene.

[45]  H. Stunnenberg,et al.  PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. , 2010, Cancer cell.

[46]  R. Nasr,et al.  RXR is an essential component of the oncogenic PML/RARA complex in vivo. , 2007, Cancer cell.